Facebook Twitter LinkedIn Google Plus RSS

Capital Health first in NJ to employ Embotrap II stroke treatment

By ,

Capital Health Regional Medical Center has become the first hospital in New Jersey to employ the Embotrap II Revascularization Device for treatment of stroke, the Trenton-based facility said.

Neurosurgeons at Capital Health’s Capital Institute for Neuroscience use Embotrap II to remove a blood clot in the brain causing a stroke. The stent retriever features a fine, mesh-like end and is guided through a major artery to trap the clot.

"As one of the tools that we use to treat ischemic stroke, Embotrap II has a design that has been shown to trap clots that are causing the blockage of blood flow in the brain while retaining its shape, making it faster and more effective at retrieving the clot, restoring blood flow to the brain and ultimately providing a better outcome," said Capital Institute for Neurosciences’ Stroke and Cerebrovascular Center’s Dr. Vernard Fennell in a release.

Fennell also participated in initial research for Embotrap II’s design.

Embotrap II received approval from the U.S. Food and Drug Administration in July.

You May Have Missed...

Jessica Perry

Jessica Perry

Jessica is the Web Editor for NJBIZ. You can reach her at jperry@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy